In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of ...

Professor Markus Sauer from the Biocentre of Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany ...

Scientists from Duke-NUS Medical School and the Singapore General Hospital have discovered that T cells—white blood cells ...

If you don't know your blood type, you're not alone. However it is important medical information to know, and here's how you ...

A joint research team has developed a biotemplating method that utilizes specific internal proteins in biological samples and ...

Legendary actor and filmmaker Mel Gibson revealed this week that he couldn't walk for months after taking the COVID vaccine.

Primary ovarian insufficiency was associated with a higher risk for autoimmune conditions including hypothyroidism and adrenal insufficiency.

Five years after the first cases of COVID-19, reports of hMPV, an obscure respiratory virus in China may understandably raise ...

Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and Mitsubishi Tanabe with deals announced on the same day.

Johnson & Johnson JNJ announced that the FDA has accepted its regulatory filing seeking the FDA’s approval for nipocalimab, ...

Ouro is planning to leverage T cell engagers to deplete B cells and “reset” the immune system to treat immune-mediated ...

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...